Match each clinical research scenario or action to the corresponding ethical concept or regulatory mechanism.
- A 12-year-old child provides affirmative agreement to participate in a clinical trial for a new asthma inhaler after the child's parents have provided formal legal permission.Pediatric Assent
- A principal investigator formally discloses receiving a $25,000 annual consulting fee from the pharmaceutical company that is sponsoring the investigator's upcoming randomized controlled trial.Financial Conflict of Interest
- An independent committee reviews unblinded interim data and halts an ongoing study ahead of schedule due to an unexpectedly high rate of severe adverse events in the experimental group.Data and Safety Monitoring Board (DSMB) Action
- A practicing physician accepts complimentary airfare and lodging directly from a medical device manufacturer to attend a recognized continuing medical education (CME) conference.Violation of Industry Interaction Guidelines
Answer
1) The 12-year-old child's agreement matches with Pediatric Assent. 2) The $25,000 consulting fee matches with Financial Conflict of Interest. 3) The independent committee halting the trial matches with Data and Safety Monitoring Board (DSMB) Action. 4) Accepting complimentary airfare matches with Violation of Industry Interaction Guidelines.
Each scenario highlights a distinct pillar of research ethics and professional conduct. Obtaining agreement from a minor is termed pediatric assent. Financial ties to sponsors constitute a conflict of interest that requires management. Halting a trial due to interim safety signals is a core function of the DSMB. Finally, accepting travel stipends from industry violates established guidelines regarding physician-industry relationships.
Step-by-Step Solution
Key Concept
Identifying correct ethical protocols and regulatory oversight mechanisms in clinical research, including pediatric assent, conflict of interest disclosures, trial safety monitoring, and physician-industry interactions.